Protocol Ledger

NCT05047172 · Phase III · ACTIVE NOT RECRUITING

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis

Interventional Phase III clinical trial protocol NCT05047172 sponsored by University of Florida in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2022-08-02 Enrollment: 1,683 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT05047172
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)1,683 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05047172
Protocol FieldVerified Registry Value
NCT IdentifierNCT05047172
Consolidated Lead SponsorUniversity of Florida
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase III
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment1,683 participants (ESTIMATED)
Registered Start Date2022-08-02
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT05047172
Hospital Research SiteLocationSite Profile
Mercy San Juan Medical CenterCarmichael, CAOpen Hospital Dossier ->
Kaiser Permanente Los Angeles Medical CenterLos Angeles, CAOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI